Moleculin Biotech
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MBRX and other ETFs, options, and stocks.About MBRX
Moleculin Biotech, Inc. is a clinical stage pharmaceutical company. It engages in the business of growing a pipeline including phase 2 clinical programs for hard-to-treat cancers and viruses.
MBRX Key Statistics
Stock Snapshot
Moleculin Biotech(MBRX) stock is priced at $0.73, giving the company a market capitalization of 14.95M. It carries a P/E multiple of -0.05.
As of 2026-09-20, Moleculin Biotech(MBRX) stock has fluctuated between $0.72 and $0.80. The current price stands at $0.73, placing the stock +0.9% above today's low and -8.4% off the high.
Moleculin Biotech(MBRX) shares are trading with a volume of 466.34K, against a daily average of 659.86K.
In the last year, Moleculin Biotech(MBRX) shares hit a 52-week high of $15.75 and a 52-week low of $0.16.
In the last year, Moleculin Biotech(MBRX) shares hit a 52-week high of $15.75 and a 52-week low of $0.16.
MBRX News
...
The latest announcement is out from Moleculin Biotech ( (MBRX) ). On September 15, 2026, Moleculin Biotech disclosed that it had received a Nasdaq Staff Determ...
Moleculin Biotech ( (MBRX) ) has issued an update. On September 14, 2026, Moleculin Biotech announced that new data on its lead drug candidate Annamycin (naxta...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.